Broker Ratings

Doximity, Inc. – Consensus ‘buy’ rating and -2.4% Downside Potential

Doximity, Inc. with ticker code (DOCS) have now 17 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $90.00 and $55.00 suggesting an average Analsyt target price of $73.41. Now with the previous closing price of $75.18 this indicates there is a potential downside of -2.4%. Also worth taking note is the 50 day moving average now sits at $57.41 while the 200 day moving average is $40.74. The market cap for the company is 14.45B. Currently the stock stands at: $76.99 USD

The potential market cap would be $14,106,395,961 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 76.99, revenue per share of $2.78 and a 11.83% return on assets.

Doximity, Inc. provides a digital platform for United States (U.S) medical professionals. The Company’s cloud-based platform provides tools to its members, which help them to collaborate with colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with medical news and research, and manage careers. The Company supports physicians in practice of medicine with mobile and clinical workflow tools, such as voice and video telehealth, secure messaging and digital faxing. The Company’s platform offers marketing, hiring, and telehealth solutions. Its marketing solutions enable pharmaceutical and health system customers to get content, services, and peer connections to medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms. Its telehealth solutions consist of software tools that include voice and video dialers, designed to connect patients with care providers.

Share on:
Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Giant with a 6.39% Potential Upside

    Doximity, Inc. (NASDAQ: DOCS) is a formidable player in the healthcare technology space, providing an essential digital platform tailored for medical professionals. Headquartered in San Francisco, Doximity has carved out

    Doximity, Inc. (DOCS): Investor Outlook on a $12.66 Billion Healthcare Innovator with a Strong Upside

    Doximity, Inc. (DOCS), a leading player in the Health Information Services industry, has become a pivotal digital platform for healthcare professionals in the United States. With a market capitalization of

    Doximity, Inc. (DOCS) Stock Analysis: Understanding the 6.86% Potential Upside for Investors

    Doximity, Inc. (DOCS), a leader in the health information services sector, has carved out a unique niche in the digital healthcare landscape. With a market capitalization of $12.29 billion, Doximity

    Dr. Martens appoints Berenberg as Joint Corporate Broker

    Dr. Martens plc has appointed Berenberg as a joint corporate broker with immediate effect, working alongside Investec and Goldman Sachs.

    Doximity, Inc. (DOCS) Stock Analysis: Revenue Growth and Analyst Ratings Boost Investor Interest

    Doximity, Inc. (NYSE: DOCS), a leading U.S.-based digital platform for medical professionals, has captured the attention of investors in the healthcare sector. With a robust market capitalization of $13.72 billion,

    Dr. Martens Plc expands into UAE and Latin America through new partnerships

    Dr. Martens has signed a distribution deal with Beside Group to enter the UAE market for the first time and partnered with Crosby in Latin America, which has opened stores

      Search

      Search